Significant Ownership of Longitude Capital Partners V, LLC
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Longitude Capital Partners V, LLC focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- Menlo Park, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
1 identity field
CIK context first
Continue from Longitude Capital Partners V, LLC
Significant Ownership of Longitude Capital Partners V, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MANE | Veradermics, Incorporated | Common Stock, $0.00001 par value per share | 9.8% | $526,004,938 | -$63,315,000 | 4,153,873 | -11% | Patrick G. Enright | 11 Nov 2026 |
| CTMX | CytomX Therapeutics, Inc. | Common Stock, $0.00001 par value per share | 7% | $65,740,382 | +$16,125,000 | 15,288,461 | +33% | Patrick G. Enright | 31 Mar 2026 |
| ENTX | Entera Bio Ltd. | Ordinary Shares, par value per share NIS 0.0000769 | 4.6% | $13,019,609 | 7,843,138 | Longitude Capital Partners V, LLC | 28 Jul 2026 |
Schedules 13D/G Reported by Longitude Capital Partners V, LLC:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.